BODIPY的设计和合成及其在抑制肠道植物中的应用
Jinyao Xu1, Hao Huang1, Kewei Wang1
1Jiangsu Provincial Engineering Research Center for Biomedical Materials and Advanced Medical Devices, Faculty of Mechanical and Material Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu 223003, China.
ACS omega
|November 11, 2024
概括
基于BODIPY的新型光敏感剂显示出对抗微生物光动力学疗法 (PDT) 的前景. 结构变化增强了PDT的效果,为细菌感染提供了潜在的新疗法,并对阿尔茨海默病的洞察力.
科学领域:
- 有机化学 有机化学
- 摄影化学的使用.
- 微生物学 微生物学
背景情况:
- 抗微生物耐药性是一个日益增长的全球健康威胁.
- 光动力疗法 (PDT) 为传统抗生素提供了一种光激活的替代方案.
- BODIPY染料以其光物理特性而闻名,使其适合PDT应用.
研究的目的:
- 合成和评估新的基于BODIPY的光敏剂,用于抗微生物光动力学治疗.
- 调查结构修改如何影响PDT中的BODIPY光敏剂的疗效.
- 探索肠道微生物群调节与阿尔茨海默病预防/治疗之间的潜在联系.
主要方法:
- 新型BODIPY衍生品的合成.
- 使用光谱技术对合成化合物的表征.
- 在体外测试抗微生物光动力学治疗对细菌菌株的疗效.
- 结构与活动关系的分析.
主要成果:
- 成功合成和表征了一系列基于BODIPY的光敏感剂.
- 证明特定的结构修改显著提高PDT的疗效.
- 观察到强大的抗微生物活性对测试的细菌病原体.
- 确定了肠道微生物群和阿尔茨海默氏症病原体之间的潜在相关性.
结论:
- 基于BODIPY的光敏感剂代表了开发新型抗菌PDT策略的有希望的平台.
- 结构优化是最大限度地提高PDT对细菌感染有效性的关键.
- 对肠道微生物群调节的进一步研究可能为阿尔茨海默病管理提供新的途径.
相关概念视频
Bacterial Flora of the Large Intestine
388
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
388
Drugs for Treatment of Constipation-Predominant IBS
136
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
136
Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
178
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
178
Biological Methods for Microbial Control
2
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
2


